Israeli biotech Novocure’s clinical study of its NovoTTF therapy for pancreatic cancer demonstrated a significant decrease in cell count and reduced tumor volume. Its effectiveness was enhanced when combined with chemotherapy.
http://www.pancreatology.net/article/S1424-3903%2813%2900844-2/abstract